Package Leaflet: Information for the User
Iszema1 mg/g cream
methylprednisolone aceponate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
It is an anti-inflammatory medicine (a corticosteroid) for use on the skin.
Iszema reduces inflammation and allergic reactions of the skin, and reactions associated with excessive cell multiplication (hyperproliferation). Therefore, it reduces redness (erythema), fluid accumulation (edema), and exudate in inflamed skin. It also relieves itching, burning, or pain.
Iszema is used in the treatment of:
Iszema, in cream form, is particularly indicated in exudative conditions (those that secrete fluid).
Do not use Iszema
Warnings and precautions
Consult your doctor or pharmacist before starting to use Iszema.
Be particularly careful if your doctor diagnoses you with a bacterial or fungal infection, as you should also use the additional treatment prescribed for the infection, because if you do not, the infection may worsen.
Contact your doctor if you experience blurred vision or other visual disturbances.
Anti-inflammatory drugs (corticosteroids), such as the active ingredient methylprednisolone aceponate, in Iszema have significant effects on the body. It is not recommended to use Iszema on large areas of skin or for extended periods, as this significantly increases the risk of side effects.
To reduce the risk of side effects:
If you use Iszema for diseases other than those for which it has been prescribed, it may mask symptoms and make diagnosis and correct treatment more difficult.
If you apply Iszema to the anal or genital area, some of its ingredients may damage latex products such as condoms or diaphragms. Therefore, they may no longer be effective as contraceptives or as protection against sexually transmitted diseases, such as HIV infection. Consult your doctor or pharmacist if you need more information.
Children
It is essential to consider that diapers can be occlusive. If the doctor weighs the benefits and risks, Iszema cream may be prescribed for use in children between 4 months and 3 years.
This medicine is not recommended for use in children under 4 months of age.
Other medicines and Iszema
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
No interactions with other medicines are known at present for Iszema cream.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
To avoid any risk to the child, do not use Iszema cream if you are pregnant or breastfeeding, unless your doctor tells you to.
If your doctor recommends using Iszema cream during breastfeeding, do not apply the medicine to the breasts; do not let the child come into contact with treated areas.
Driving and using machines
This medicine does not affect your ability to drive or use machines.
Iszema contains cetyl alcohol, benzyl alcohol, and butylhydroxytoluene
This medicine may cause local skin reactions (such as contact dermatitis) because it contains cetyl alcohol.
This medicine contains 10 mg of benzyl alcohol in each gram of cream. Benzyl alcohol may cause allergic reactions and moderate local irritation.
This medicine may cause local skin reactions (such as contact dermatitis) or eye and mucous membrane irritation because it contains butylhydroxytoluene.
Follow exactly the administration instructions of this medicine indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
This medicine is for cutaneous use (to be applied to the skin)
Unless your doctor tells you otherwise, the recommended dose is:
If during treatment the skin becomes too dry, consult your doctor. Depending on the type of skin affected, it is recommended to change the treatment to another methylprednisolone medicine with a higher fat content (ointment or ointment).
Use in children
Iszema must not be used in children under four months of age due to lack of safety data.
Treatment duration in children should be limited to the minimum, generally not exceeding 4 weeks.
If you use more Iszema than you should
No risk of acute intoxication is expected after a single cutaneous application of an overdose (application to a large area, in circumstances favorable for absorption) or after accidental ingestion. Repeated overdoses may produce side effects (see section 4. Possible side effects).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to a medical center, or call the Toxicology Information Service, phone 91 562 04 20 (indicating the medicine and the amount ingested).
If you forget to use Iszema
Do not use a double dose to make up for forgotten doses. If you have forgotten a dose, continue with your usual schedule as indicated by your doctor or as described in the package leaflet.
If you stop using Iszema
If you stop treatment prematurely, the original symptoms of your skin problem may reappear. Contact your doctor before stopping treatment with Iszema cream.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
Burning and itching at the application site
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Side effects with frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use, Website: www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Once the carton is opened, discard the tube with the remaining cream after 2 years.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Iszema
Appearance and packaging
Iszema cream is a white opaque cream.
This medicine is presented in aluminum tubes containing 30 and 60 grams of cream.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Isdin S.A.
Provençals 33
08019 Barcelona
Spain
Manufacturer
Bioglan AB
Borrgatan 31, 211 24 Malmö
Sweden
Date of last revision of this leaflet: August 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/